Dirk Sibbing Shares a Recent ”Excellent Study” on Clopidogrel Versus Aspirin by Marco Valgimigli and Colleagues
Dirk Sibbing, Professor, Cardiologist and Angiologist at Privatklinik Lauterbacher Mühle and LMU Munich, reposted from Claudio Laudani on LinkedIn:
”Excellent study with clinically important results, especially in light of recent data at ESC 2025 in Madrid on hashtag#clopidogrel in secondary prevention for CAD patients after PCI. Valgimigli et al., Lancet 2025”
Read the full article here.
Article: Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
Auhtors: Marco Valgimigli, Ki Hong Choi, Daniele Giacoppo, Felice Gragnano, Takeshi Kimura, Hirotoshi Watanabe, Hyo-Soo Kim, Jeehoon Kang, Kyung Woo Park, Alf-Åge Pettersen, Mark Woodward, Deepak L Bhatt, Paolo Calabrò, Dominick J Angiolillo, Roxana Mehran, Young Bin Song, Joo-Yong Hahn
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared a post on LinkedIn:
”Race has been shown to have a significant influence on clinical outcomes in patients with atherosclerotic cardiovascular disease.
However, the mechanisms behind such association are still poorly understood.
In this manuscript, we explored biological condition that may be responsible for such association, finding that among participant with atherosclerotic cardiovascular disease on chronic clopidogrel treatment, Black individuals have higher platelet reactivity (related to P2Y12 receptor activity) compared to non-Black individual.
In addition, we further confirmed the increased risk of MACE and myocardial infarction of Black individuals compared to non-black individuals among patients with coronary artery disease undergoing PCI.
These data highlight how further efforts are needed to reduce disparities between races, focusing on both healthcare access and biological process to guide the decision-making.”
Rad the full article here.
Article: Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants
Authors: Luis Ortega-Paz, Cameron D. Thomas, Claudio Laudani, Salvatore Giordano, Francesco Franchi, Kayla R. Tunehag, Fabiana Rollini, Selina Durukan, Joseph S. Rossi, Maryam Farahmandsadr, George A. Stouffer, Latonya Been, Ellen C. Keeley, Julio D. Duarte, Amber L. Beitelshees, Craig R. Lee, Larisa H. Cavallari, Dominick J. Angiolillo
Stay updated on all science in the field of coagulation with Hemostasis Today.
-
Apr 23, 2026, 14:46Mital Jhaveri: Anticoagulant Approval and Uptake Timeline
-
Apr 23, 2026, 14:42Salih Ehsan: Bradykinin-Mediated Transfusion Reactions in Patients on ACE Inhibitors
-
Apr 23, 2026, 14:39Mona Alfaraj: Don’t Miss the Chance to Be Part of the 2nd International Hematology and Hemostasis Conference
-
Apr 23, 2026, 14:11Emerging Contributions to Hemostasis from Recipients of the Christine Lee Young Researcher Awards – WFH
-
Apr 23, 2026, 13:52Joffrey Feriel: A Revised ISTH Definition of Disseminated Intravascular Coagulation
-
Apr 23, 2026, 13:39Mazou Ngou Temgoua: Cancer and VTE – Toward Truly Personalized Anticoagulation
-
Apr 23, 2026, 13:35Jecko Thachil: Risk Assessment and Clinical Management of Nephrotic Syndrome–Associated Thrombosis
-
Apr 23, 2026, 12:18Mona Ranade: A Contemporary Framework for Managing Right Heart Thrombus in PE
-
Apr 23, 2026, 11:59Strengthening Hemophilia Care Through Collaboration and Commitment in India at IHC X 2026 – Hemophilia Federation India